Reference standard comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-10-04. Numbers and descriptions here follow the published literature rather than marketing material.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ | Nuclear receptor; not androgen receptor |
| Studied indications | Dyslipidemia; obesity; diabetes | Early clinical research; development discontinued |
| Rodent toxicity | Tumor formation in multiple tissues | Dose-dependent findings in some studies |
| Human approval | None | No approved therapeutic use |
| Typical analytical method | LC-MS/MS | Used for identity and quantification |
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
== Function == Gastric inhibitory polypeptide, also called glucose-dependent insulinotropic polypeptide, is a 42-amino acid polypeptide synthesized by K cells of the duodenum and small intestine. It was originally identified as an activity in gut extracts that inhibited gastric acid secretion and gastrin release, but subsequently was demonstrated to stimulate insulin release potently in the presence of elevated glucose. The insulinotropic effect on pancreatic islet beta-cells was then recognized to be the principal physiologic action of GIP. Together with glucagon-like peptide-1, GIP is largely responsible for the secretion of insulin after eating. It is involved in several other facets of the anabolic response.
The magnocellular cells in the PVN elaborate and secrete two peptide hormones: oxytocin and vasopressin. These hormones are packaged into large vesicles, which are then transported down the unmyelinated axons of the cells and released from neurosecretory nerve terminals residing in the posterior pituitary gland. Similar magnocellular neurons are found in the supraoptic nucleus which also secrete vasopressin and oxytocin.
Pickens reprised the role in two episodes of the 10th season revival and currently (2019) appears on a recurring basis on The Conners. Mr. Parkin (Stan Freberg) – A highly qualified man who is frequently unemployed due to various incidents with the Conners. Scott (Fred Willard) – A probate attorney who marries Leon. Stinky (Matthew Fishman) – Roseanne's youngest child in an alternate reality, in the place of Jerry. Ziggy (Jay O. Sanders) – An old friend of the Conners. Roseanne reveals that his real name is Norbert, then asks, "does your mom still call you Norbie?" Ziggy helps Dan open Lanford Custom Cycle, then disappears. Jimmy Gartner (Danny Masterson) – Darlene's boyfriend, for whom she breaks up with David. In the 16th episode of season 7, Darlene confesses to Jackie that he broke up with her because he could not get close to her. Ronnie (Joan Collins) – Roseanne's rich cousin who persuades Darlene to get her GED and apply to art school.
== Career == After postdoctoral research at AMOLF (FOM Institute for Atomic and Molecular Physics, Amsterdam) and University of Minnesota, Hamley was appointed as lecturer in Physics at the University of Durham in 1993 where he worked until 1995. He moved to the Department of Chemistry at the University of Leeds in 1995 and was promoted to become Professor of Polymer Materials and Director of the Centre for Self-Organising Molecular Systems in 2004. He moved to the University of Reading as Diamond Professor of Physical Chemistry in 2005. This was a five-year, joint appointment with Diamond Light Source. His past research concerned the self-assembly of block copolymers. Most recently he has developed interests in peptide and peptide conjugate self-assembly, including molecules with bioactivity such as amyloid peptides peptide hormones, antimicrobial peptides, peptides in cosmetic applications and peptides with anti-cancer activity. Several of these show promise as therapeutics.
Suanmeitang is a sweet Chinese beverage made from smoked plums. Soy milk, almond milk, walnut milk and coconut milk are also drunk during the meal in different regions. In some parts of China, hawthorn and jujube juice are preferred. A small shot of fruit vinegar is served as an appetizer in Shanxi. Nai lao or Beijing yogurt is a drinkable yogurt traditional to northern China.
Sources: en.wikipedia.org
February 4: Abolition of slavery in French colonies (not applied in some later-acquired colonies; slavery reestablished in most colonies from 1802, except Saint-Domingue, independent in 1804). March 12: Possibility to annul religious vows made before age 18 for girls or 21 for boys. 1795
==== More Teachers ==== In January 2025, the "More Teachers" program was launched with the aim of increasing the presence of teachers in regions farther from the country's main urban centers. The program provides monthly scholarships of 2,100 reais to teachers with specific training who work in regions with a greater shortage of professionals, such as in the areas of physics, mathematics and biology. The program includes integrated actions to strengthen teacher training, encourage entry into public teaching, and enhance the professional recognition of educators. A National Teacher Examination will be implemented to assist states, the Federal District and municipalities in recruitment and hiring processes for teaching positions, and the Pé-de-Meia Licensure Scholarship will aim to promote entry into, retention in and completion of teacher training courses.
==== Reward circuitry ==== NOP is highly expressed in every node of the mesocorticolimbic reward circuitry. Unlike MOP agonists such as codeine and morphine, NOP agonists do not have reinforcing effects. Nociceptin is thought to be an endogenous antagonist of dopamine transport that may act either directly on dopamine or by inhibiting GABA to affect dopamine levels. In animal models, the result of NOP activation in the central nervous system has been shown to eliminate conditioned place preference induced by morphine, cocaine, alcohol, and methamphetamine.
== Interactions == The actions and effects of muscimol may be potentiated by benzodiazepines such as diazepam. Diazepam has been found to strongly potentiate the central depressant effects of muscimol in rodents. Conversely, the barbiturate phenobarbital did not potentiate the effects of muscimol in rodents. Neurosteroids like allopregnanolone and pregnanolone may potentiate the effects of muscimol.
In May 1952, Raymond Gosling, a graduate student working under the supervision of Rosalind Franklin, took an X-ray diffraction image, labeled as "Photo 51", at high hydration levels of DNA. This photo was given to Watson and Crick by Maurice Wilkins and was critical to their obtaining the correct structure of DNA. Franklin told Crick and Watson that the backbones had to be on the outside. Before then, Linus Pauling, and Watson and Crick, had erroneous models with the chains inside and the bases pointing outwards. Franklin's identification of the space group for DNA crystals proved her correct. In February 1953, Linus Pauling and Robert Corey proposed a model for nucleic acids containing three intertwined chains, with the phosphates near the axis, and the bases on the outside. Watson and Crick completed their model, which is now accepted as the first correct model of the double helix of DNA. On 28 February 1953 Crick interrupted patrons' lunchtime at The Eagle pub in Cambridge, England to announce that he and Watson had "discovered the secret of life".
Sources: en.wikipedia.org
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.
Rodent studies found dose-dependent tumors in several organs. The sponsor discontinued the program over cancer concerns. Human risk from long-term use remains unknown.
Controlled human endurance trials are lacking. Animal studies show increased exercise capacity under some conditions. Anecdotal reports are not equivalent to clinical evidence.
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.